HIV-1_pr45I-47V-50V

ANTIVIRAL RESISTANT STRAIN


EVAg

Produced by
: UNIBAS
Shipping From
: Basel - CH

Product Description

Ref-SKU:
006V-02658
HIV-1 variant, infectious recombinant virus with specific mutations in the protease gene as indicated. These mutations confer resistance to specific HIV protease inhibitors and have been reported for emerging virus in vivo.
Product Risk Group: 
Subspecies: 
Group M virus
Strain: 
Subtype B
Isolate: 
point-mutated recombinant

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
>10e8 RNA copies (>10e6 infectious particles)

In stock

2 000,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Special feature: 
GMO: 
No
Biosafety restrictions: 
infectious material; strictly for handling within BSL-3 environment
Infectivity Test: 
infection of susceptible human cell lines (Hut78, 293T, CEM, SX22-1 as Hela-derivative)
Viral titer: 
10e7 particles / mL
Production cell line: 
Collection date: 
Friday, 1 January, 2010
Isolation host: 
Isolation technique: 
site-specific mutagenesis in accordance with mutations found in sequences from patient-derived virus
Clinical information: 
Derived from emerging drug-resistant virus from patient with elevated viral load.
Passage: 
1
Shipping conditions: 
IATA Classification: